poisar

Stock

Rapport Therapeutics, Inc. RAPP

$50.89-3.15%

Overview

RAPP market data

Price History

RAPP price chart · 1M
O
51.96
H
52.93
L
50.71
C
50.89
Vol
23,114.00
Source
US equities market feed
Observed
Aug 27, 2026, 12:00 AM
Cadence
Five-minute page cache; daily and stored hourly bars
Status
fresh

Key Stats & Performance

Open
$51.96
Previous Close
$52.55
Day High
$52.93
Day Low
$50.71
52 Week High
$52.93
52 Week Low
$32.41
7 Day Return
+6.20%
30 Day Return
+21.25%
90 Day Return
+28.87%
1 Year Return
+54.21%
Daily Notional Volume
$1.2M
Latest daily bar volume multiplied by its closing price.

Valuation & Profitability

Provider-backed
P/E (TTM)
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
-$2.86
Diluted earnings per share over the trailing twelve months.
Beta
2.47
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$14.11 – $51.38
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · market cap $2.3B · P/B 2.98.

Company News

5 captured
BTIG Reiterates Buy on Rapport Therapeutics, Maintains $65 Price TargetBenzinga · Aug 19, 2026, 10:25 AM
HC Wainwright & Co. Maintains Buy on Rapport Therapeutics, Raises Price Target to $66Benzinga · Aug 12, 2026, 4:58 PM
Rapport Therapeutics Q2 EPS $(1.19) Misses $(0.96) EstimateBenzinga · Aug 5, 2026, 11:24 AM
8-K filing — Rapport Therapeutics, Inc. (RAPP)SEC EDGAR · Aug 5, 2026, 11:17 AM
Leerink Partners Initiates Coverage On Rapport Therapeutics with Outperform Rating, Announces Price Target of $52Benzinga · Jun 24, 2026, 6:45 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock
Rapport Therapeutics, Inc. (RAPP) stock — price, valuation & news | Poisar